RLI Corp. (RLI) Trades at $66.80 After Triangle; Profile of 3 Analysts Covering CONMED (CNMD)

RLI Corp. (NYSE:RLI) Logo

RLI Corp. (RLI) formed triangle with $64.13 target or 4.00% below today’s $66.80 share price. RLI Corp. (RLI) has $2.96B valuation. The stock increased 0.06% or $0.04 during the last trading session, reaching $66.8. About 105,967 shares traded. RLI Corp. (NYSE:RLI) has risen 8.68% since May 11, 2017 and is uptrending. It has underperformed by 2.87% the S&P500.

Among 6 analysts covering CONMED Corporation (NASDAQ:CNMD), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. CONMED Corporation had 19 analyst reports since July 22, 2015 according to SRatingsIntel. Needham maintained the stock with “Buy” rating in Thursday, April 28 report. The stock has “Buy” rating by Needham on Friday, November 17. The firm has “Hold” rating by KeyBanc Capital Markets given on Wednesday, August 23. The firm has “Buy” rating given on Thursday, April 26 by Needham. KeyBanc Capital Markets maintained CONMED Corporation (NASDAQ:CNMD) on Friday, November 3 with “Hold” rating. The rating was downgraded by Northland Capital to “Market Perform” on Wednesday, July 22. Piper Jaffray maintained the stock with “Hold” rating in Friday, November 3 report. The company was upgraded on Monday, October 12 by Ladenburg Thalmann. The stock of CONMED Corporation (NASDAQ:CNMD) has “Buy” rating given on Thursday, August 31 by Needham. Needham maintained CONMED Corporation (NASDAQ:CNMD) on Thursday, July 27 with “Buy” rating. See CONMED Corporation (NASDAQ:CNMD) latest ratings:

26/04/2018 Broker: Needham Rating: Buy New Target: $73.0000 Maintain
01/02/2018 Broker: Piper Jaffray Rating: Hold New Target: $54.0 Maintain
01/02/2018 Broker: Needham Rating: Buy New Target: $71.0 Maintain
17/11/2017 Broker: Needham Rating: Buy New Target: $58.0 Maintain

Investors sentiment increased to 1.57 in 2017 Q4. Its up 0.21, from 1.36 in 2017Q3. It increased, as 7 investors sold RLI Corp. shares while 49 reduced holdings. 27 funds opened positions while 61 raised stakes. 37.42 million shares or 3.33% more from 36.22 million shares in 2017Q3 were reported. 99,948 are held by Parametric Associate Limited Liability Company. Franklin holds 368,018 shares or 0.01% of its portfolio. Markel Corporation accumulated 1.20 million shares. Rocky Mountain Advisers holds 66 shares or 0.02% of its portfolio. Pictet Asset accumulated 222,937 shares. Jfs Wealth Advsr Lc reported 35 shares or 0% of all its holdings. Fdx Advsr Inc accumulated 9,433 shares. Pub Employees Retirement Systems Of Ohio holds 0.01% or 39,600 shares. Neuberger Berman Grp Lc holds 2.24 million shares. 69 are owned by Fifth Third Commercial Bank. Captrust Advsr invested in 110 shares. Thomson Horstmann & Bryant holds 0.07% in RLI Corp. (NYSE:RLI) or 8,801 shares. Snyder Capital Management L P holds 423,077 shares or 1.28% of its portfolio. Sg Americas accumulated 5,623 shares or 0% of the stock. Bbva Compass Bancorp owns 16,940 shares for 0.07% of their portfolio.

Among 6 analysts covering RLI Corporation (NYSE:RLI), 0 have Buy rating, 3 Sell and 3 Hold. Therefore 0 are positive. RLI Corporation had 25 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Monday, August 3 by FBR Capital. On Tuesday, September 5 the stock rating was maintained by RBC Capital Markets with “Sell”. The stock of RLI Corp. (NYSE:RLI) earned “Hold” rating by FBR Capital on Friday, April 21. RBC Capital Markets maintained RLI Corp. (NYSE:RLI) on Thursday, April 19 with “Sell” rating. The firm has “Sell” rating given on Tuesday, May 23 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Monday, July 31 with “Sell”. The stock has “Sector Perform” rating by RBC Capital Markets on Wednesday, October 21. The firm has “Sell” rating given on Monday, October 9 by RBC Capital Markets. The stock of RLI Corp. (NYSE:RLI) has “Market Perform” rating given on Thursday, January 7 by Keefe Bruyette & Woods. FBR Capital maintained the shares of RLI in report on Thursday, September 3 with “Mkt Perform” rating.

Since January 4, 2018, it had 1 buy, and 7 selling transactions for $1.59 million activity. RESTREPO ROBERT P JR bought $43,490 worth of RLI Corp. (NYSE:RLI) on Monday, January 29. $99,617 worth of RLI Corp. (NYSE:RLI) was sold by AHLMANN KAJ on Monday, April 23. $67,778 worth of RLI Corp. (NYSE:RLI) was sold by STONE MICHAEL J. Diefenthaler Aaron Paul also sold $58,291 worth of RLI Corp. (NYSE:RLI) shares.

Investors sentiment decreased to 1.3 in 2017 Q4. Its down 0.04, from 1.34 in 2017Q3. It turned negative, as 7 investors sold CONMED Corporation shares while 46 reduced holdings. 25 funds opened positions while 44 raised stakes. 26.91 million shares or 0.87% less from 27.14 million shares in 2017Q3 were reported. Pinebridge Investments Ltd Partnership stated it has 0.06% in CONMED Corporation (NASDAQ:CNMD). Parallax Volatility Advisers Lp owns 4,200 shares. New York State Teachers Retirement System holds 0.01% in CONMED Corporation (NASDAQ:CNMD) or 62,091 shares. The Washington-based Fisher Asset Mgmt Ltd Liability Com has invested 0.04% in CONMED Corporation (NASDAQ:CNMD). Citadel Advsr Limited accumulated 34,921 shares. Gabelli Funds Ltd Company has invested 0.02% in CONMED Corporation (NASDAQ:CNMD). Profund Advisors Limited has invested 0.01% of its portfolio in CONMED Corporation (NASDAQ:CNMD). Pacad Investment, British Columbia – Canada-based fund reported 100 shares. 1.02M are owned by Cramer Rosenthal Mcglynn Ltd Limited Liability Company. Cna Fin has 5,503 shares. Tiaa Cref Mgmt Limited Liability Company invested in 68,223 shares or 0% of the stock. Champlain Invest Prtn Ltd Liability accumulated 1.48 million shares. Ubs Asset Mgmt Americas reported 12,660 shares or 0% of all its holdings. Employees Retirement Association Of Colorado holds 5,159 shares or 0% of its portfolio. Burney has invested 0.04% in CONMED Corporation (NASDAQ:CNMD).

Since January 3, 2018, it had 1 buying transaction, and 9 sales for $3.90 million activity. $7,996 worth of CONMED Corporation (NASDAQ:CNMD) was bought by Farkas Charles. 3,000 CONMED Corporation (NASDAQ:CNMD) shares with value of $191,694 were sold by GOLDEN JO ANN. $1.14 million worth of CONMED Corporation (NASDAQ:CNMD) was sold by POMILIO LUKE A. On Friday, April 27 JONAS DANIEL sold $131,160 worth of CONMED Corporation (NASDAQ:CNMD) or 2,000 shares. Berge Terence M sold 3,868 shares worth $241,574. On Friday, April 27 Folkert Nathan sold $286,497 worth of CONMED Corporation (NASDAQ:CNMD) or 4,409 shares.

More news for CONMED Corporation (NASDAQ:CNMD) were recently published by: Benzinga.com, which released: “Benzinga’s Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway” on May 09, 2018. Globenewswire.com‘s article titled: “Market Trends Toward New Normal in Cohen & Steers, Achaogen, Ares Commercial Real Estate, CONMED, Marcus …” and published on May 02, 2018 is yet another important article.

CONMED Corporation, a medical technology company, develops, makes, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $1.90 billion. The firm offers sports medicine products, such as powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bio absorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; and sports biologics and tissues. It has a 34.39 P/E ratio. It also provides electrosurgical generators, hand pieces, smoke management systems, and accessories for surgical needs; and endomechanical instrumentation products that offer various instruments comprising trocars, suction irrigation devices, graspers, scissors, and dissectors used in the minimally invasive laparoscopic and gynecological surgery, as well as an uterine manipulator for use in the laparoscopic hysterectomies and other gynecologic laparoscopic procedures.

The stock decreased 0.46% or $0.31 during the last trading session, reaching $67.75. About 95,834 shares traded. CONMED Corporation (NASDAQ:CNMD) has risen 46.44% since May 11, 2017 and is uptrending. It has outperformed by 34.89% the S&P500.

RLI Corp. (NYSE:RLI) Institutional Positions Chart